Secretomix®-based Therapeutics

About Micregen

Micregen is a private, pre-clinical stage biotech leveraging its proprietary Secretomix® platform to create multi-factorial, stem cell-derived secretome products. The platform is designed to overcome limitations of whole cell therapies by producing scalable, consistent, and easily administered biologics that target multiple pathways of degeneration simultaneously. The company's vision is to address complex, under-served conditions in longevity and degenerative diseases through a novel, cell-free approach in regenerative medicine. Initial commercial positioning appears to be in the aesthetic and anti-aging market, serving as a potential pathway to broader therapeutic applications.

Therapeutic Areas